These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13335861)

  • 1. [Treatment of hemorrhagic thrombocytopenia with injection of human fibrinogen in high doses].
    CAZAL P; GRAAFLAND R; IZARN P; MATHIEU M; PALEIRAC G; FISCHER J
    Presse Med (1893); 1956 Apr; 64(29):670-1. PubMed ID: 13335861
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombocytopenic hemorrhages arrested by intravenous injection of human fibrinogen].
    CAZAL P; GRAAFLAND R; IZARN P; MATHIEU M; PALEIRAC G; FISCHER J
    Sang; 1956; 27(1):84-7. PubMed ID: 13337108
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemostatic action of human fibrinogen in large doses].
    CAZAL P; GRAAFLAND R; IZARN P; MATHIEU M; PALEIRAC G; FISCHER J
    Acta Haematol; 1956 Jun; 15(6):337-48. PubMed ID: 13339095
    [No Abstract]   [Full Text] [Related]  

  • 4. [The maximum width of the thromboelastogram studied as a function of the platelets and fibrinogen in leptospirosis].
    GRAZIOLI C; MONTEVERDE A; FUMAGALLI E
    Folia Med (Napoli); 1962 Oct; 45():886-96. PubMed ID: 13950019
    [No Abstract]   [Full Text] [Related]  

  • 5. EFFECT OF FIBRINOGEN ON THE AGGREGATION OF PLATELETS BY ADENOSINE DIPHOSPHATE.
    CROSS MJ
    Thromb Diath Haemorrh; 1964 Dec; 12():524-7. PubMed ID: 14254709
    [No Abstract]   [Full Text] [Related]  

  • 6. [FIBRINOGEN CLEAVAGE PRODUCTS AND HEMOSTASIS].
    KOWALSKI E; BUDZYNSKI Z; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Z Gesamte Inn Med; 1965 Mar; 20():SUPPL:296-300. PubMed ID: 14306479
    [No Abstract]   [Full Text] [Related]  

  • 7. FIBRINOGEN-POOR PLATELETS AS ONE OF THE DEFECTS IN GLANZMANN PURPURA.
    FERREIRA HC; SILVA MP; MURAT LG; FERRAZ CN
    Rev Hosp Clin Fac Med Sao Paulo; 1964; 19():293-300. PubMed ID: 14251060
    [No Abstract]   [Full Text] [Related]  

  • 8. [STUDIES ON THE INDUCTION OF VISCOUS METAMORPHOSIS OF HUMAN BLOOD PLATELETS BY IMMUNE COMPOUNDS].
    BETTEX-GALLAND M; LUESCHER EF
    Pathol Microbiol (Basel); 1964; 27():533-41. PubMed ID: 14178192
    [No Abstract]   [Full Text] [Related]  

  • 9. Some observations on the blood-clotting mechanism; the role of fibrinogen and platelets, with reference to a case of congenital afibrinogenaemia.
    PINNIGER JL; PRUNTY FT
    Br J Exp Pathol; 1946 Jun; 27(3):200-10. PubMed ID: 20995649
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the mechanism of thrombin-catalyzed hemostatic reactions in blood platelets.
    GRETTE K
    Acta Physiol Scand Suppl; 1962; 195():1-93. PubMed ID: 13950336
    [No Abstract]   [Full Text] [Related]  

  • 11. Five cases of hypofibrinogenaemic haemorrhage in pregnancy treated with fibrinogen manufactured from human plasma.
    EJBY-POULSEN P; BRANDT-NIELSEN E
    Acta Obstet Gynecol Scand; 1958; 37(4):472-81. PubMed ID: 13605695
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of ketone bodies on fibrinogen, thrombocytes, and fibrinolysin activity in rabbits.
    BRAHMANKAR DM; NATH MC
    Am J Physiol; 1963 Apr; 204():653-4. PubMed ID: 14014885
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma fibrinogen in chronic neurological diseases, with special reference to disseminated sclerosis.
    PERSSON I
    Acta Psychiatr Neurol Scand; 1955; 30(4):659-64. PubMed ID: 13301919
    [No Abstract]   [Full Text] [Related]  

  • 14. [The mechanism of blood sedimentation. VI. On accelerated blood sedimentation and fibrinogen increase by lipopolysaccharide injection in experimental animals].
    BRITTINGER G; KAYSER FH; NASS G; RUHENSTROTH-BAUER G
    Z Naturforsch B; 1962 Sep; 17B():606-9. PubMed ID: 14040835
    [No Abstract]   [Full Text] [Related]  

  • 15. CHYMORAL AND COAGULATION.
    PESSEREAU G; MONTEIL R
    Rev Int Serv Sante Armees; 1963 Dec; 36():745-57. PubMed ID: 14102522
    [No Abstract]   [Full Text] [Related]  

  • 16. CHANGES IN BLOOD PROACCELERIN (FACTOR V) IN RATS WITH INTESTINAL STRANGULATION OBSTRUCTION.
    HAUGE A; AMUNDSEN E; WAALER BA
    Thromb Diath Haemorrh; 1964 Oct; 12():49-63. PubMed ID: 14224645
    [No Abstract]   [Full Text] [Related]  

  • 17. BLOOD LOSS ASSOCIATED WITH ADMINISTRATION OF LOW MOLECULAR WEIGHT DEXTRAN.
    GARZON AA; FINK LH; SHAFTAN GW; KARLSON KE
    J Thorac Cardiovasc Surg; 1964 Dec; 48():873-80. PubMed ID: 14239975
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE BEHAVIOR OF DIFFERENT BLOOD COAGULATION FACTORS IN IRRADIATION OF GYNECOLOGICAL CARCINOMA WITH COBALT 60].
    GRAEBER W
    Strahlentherapie; 1964 May; 124():60-8. PubMed ID: 14216959
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on afibrinogenemia. II. The defibrinating effect on dog blood of intravenous injection of thromboplastic material.
    RATNOFF OD; CONLEY CL
    Bull Johns Hopkins Hosp; 1951 May; 88(5):414-24. PubMed ID: 14830934
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrinogen during hemorrhagic states; the great pseudo-hemophilic afibrinemias; afibrinemic acute purpuras; pseudo-hemogenetic hypofibriemia].
    CROIZAT P; REVOL L; FAVRE-GILLY J
    Lyon Med; 1947 Aug; 177(33):537-45. PubMed ID: 20269564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.